BirchBioMed Inc.
OperatingBiotech · King City
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Apr 25, 2025| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Shares | 32,884,783 | — | 100.0% | — |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Charles N. Ellis, Director400K (1.22%) Sep 2024 → 480K (1.46%) Apr 2025
- Mark S. Miller, CEO and Director21M (64.1%) Sep 2024 → 21M (64.4%) Apr 2025
- Maxim Partners LLC3.8M (11.6%) Jul 2024 → 3.8M (11.4%) Apr 2025
- Susan Elliott, CMO and Director21M (64.7%) Sep 2024 → 21M (64.9%) Apr 2025
- Teresa Bair, Director240K (0.73%) Sep 2024 → 320K (0.97%) Apr 2025
- Jon S. Verbeck, CFO100K (0.3%) Sep 2024 → 180K (0.55%) Apr 2025
- Joseph Sardano, Director450K (1.37%) Sep 2024 → 530K (1.61%) Apr 2025
Principal holders% as the filing states it, Apr 25, 2025
- Mark S. Miller, CEO and Director21,168,672 Common Shares62.8%of company
- Susan Elliott, CMO and Director21,340,000 Common Shares62.4%of company
- Trivest Global Holdings Limited20,000,000 Common Shares60.8%of company
- Ryan Hartwell20,000,000 Common Shares60.8%of company
- Maxim Partners LLC3,750,000 Common Shares11.4%of company
- Karl Brenza, et. al.1,750,000 Common Shares5.3%of company
- Joseph Sardano, Director530,000 Common Shares1.6%of company
- Charles N. Ellis, Director480,000 Common Shares1.4%of company
- Teresa Bair, Director320,000 Common Shares1%of company
- Jon S. Verbeck, CFO180,000 Common Shares—of votes
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 19 filings on EDGAR- Form D/AOct 1, 20250000891839-25-000057EDGAR
- Form DJul 11, 20250001670747-25-000003EDGAR
- Form 1-ZJun 30, 20250001641172-25-017138EDGAR
- Form 1-A-WMay 15, 20250001641172-25-010669EDGAR
- Form 1-A POSApr 25, 20250001641172-25-006176EDGAR
- Form 1-KApr 11, 20250001641172-25-003899EDGAR
- Form 1-UApr 11, 20250001641172-25-003898EDGAR
- Form 1-UJan 30, 20250001493152-25-004267EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.